Article Information
History
- July 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anthony Kusnadi1,6,
- Ciro Ramírez-Suástegui1,6,
- Vicente Fajardo1,6,
- Serena J Chee2,6,
- Benjamin J Meckiff1,
- Hayley Simon1,
- Emanuela Pelosi3,
- Grégory Seumois1,
- Ferhat Ay1,
- Pandurangan Vijayanand1,4,5,7,* and
- Christian H Ottensmeier1,4,7,*
- 1La Jolla Institute for Immunology, La Jolla, CA, USA
- 2NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK
- 3Southampton Specialist Virology Centre, Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK
- 4Liverpool Head and Neck Center, Institute of Translational Medicine, University of Liverpool & Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom
- 5Department of Medicine, University of California San Diego, La Jolla, CA, USA
- ↵*Correspondence: P.V. (vijay{at}lji.org) or C.H.O (cottensmeier{at}lji.org)
Posted July 10, 2020.
Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8+ T cells
